However, many patients with asthma do not have eosinophilia, and even in patients with eosinophilic asthma, mepolizumab had no effect on other physiological and clinical factors.

• 但是，很多哮喘病人没有嗜酸粒细胞增多，甚至在一些嗜酸粒细胞哮喘的病人中，美泊利单抗对其他的病理和临床因子无效。”